GenFleet’s shares doubled in their first day of trading on the Hong Kong Exchange, signaling strong investor appetite for biotech equities in the region. This IPO continues the momentum of biotech listings in Hong Kong, highlighted by filings from Ark, Atom, and others. The debut also reflects growing capital flows into Asian biotech startups and biopharma innovation ecosystems.